ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph I. Miller, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thourani, V. H.
Right arrow Articles by Miller, J. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thourani, V. H.
Right arrow Articles by Miller, J. I., Jr
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1999;67:1829-1830
© 1999 The Society of Thoracic Surgeons


Correspondence

Reply

Vinod H. Thourani, MDa, Joseph I. Miller, Jr, MDa

a Division of Cardiothoracic Surgery, Department of Surgery, Section of General Thoracic Surgery, Emory University School of Medicine, 25 Prescott St, Suite 3420, Atlanta, GA 30308, USA

To the Editor

We appreciate the opportunity to reply to the comments by Drs Riquet, Hubsch and Chehab concerning our article [1]. As pointed out by Riquet and colleagues, their group in Paris, France have previously reported on pleural drainage for the treatment of the purulent chest effusions [2]. In that series, the majority of their patients appear to have had a parapneumonic effusion or empyema that were, by definition, simple in origin. Single chest tubes were utilized in 74.5% of the patients and multiple chest tubes in the remaining. Average length of stay was 21 days and the range was 2 to 72 days.

In our series, the majority of patients presented with multiloculated, complex effusions of various etilogies and in many, but not all of htese patients, fibrinolytics were tried. We agree with Riquet and colleagues that in early, simple parapneumonic effusions or empyemas that chest tube drainage treatment with fibrinolytics (urokinase being the fibrinolytic of choice) should be the first modality of treatment. However, in our series, we had an increased number of patients with multiloculated, complex parapneumonic empyemas in which case, early surgical intervention proved to be more therapeutic and cost-effective.

References

  1. Thourani V.H., Brady K.M., Mansour K.A., Miller J.I., Jr, Lee R.B. Evaluation of treatment modalities for thoracic empyema: a cost-effective analysis. Ann Thorac Surg 1998;66:1121-1127.[Abstract/Free Full Text]
  2. Debesse B., Bellamy J., Dumouchel A., et al. Drainage pleural et eradication du foyer pulmonaire. Traitement standard des pleuresies purulentes aigues a germes banals (113 cas). Rev Fr Mal Resp. 1983;11:245-246.

Related Article

Treatment modalities for thoracic empyema: the right indication for the right disease
Marc Riquet, Jean-Pierre Hubsch, and Antoine Chehab
Ann. Thorac. Surg. 1999 67: 1829. [Extract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph I. Miller, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thourani, V. H.
Right arrow Articles by Miller, J. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thourani, V. H.
Right arrow Articles by Miller, J. I., Jr
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS